D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CALL
Danaher
DHR
$149B
| $2.5M | ﹤0.01% |
10,000
-10,000
| -50% | -$2.44M |
|
2327
East-West Bancorp
EWBC
$17.4B
| $2.49M | ﹤0.01% |
31,475
-237,502
| -88% | -$17.4M |
|
2328
BlackRock Capital Allocation Term Trust
BCAT
$1.52B
| $2.49M | ﹤0.01% |
149,355
-253,676
| -63% | -$3.93M |
|
2329
Black Hills Corp
BKH
$5.37B
| $2.49M | ﹤0.01% |
+45,572
| New | +$2.39M |
|
2330
Red Rock Resorts
RRR
$3.01B
| $2.48M | ﹤0.01% |
41,511
-133,503
| -76% | -$7.4M |
|
2331
iShares MSCI Brazil Small-Cap ETF
EWZS
$241M
| $2.48M | ﹤0.01% |
170,485
+151,293
| +788% | +$2.14M |
|
2332
Terex
TEX
$6.75B
| $2.48M | ﹤0.01% |
38,488
-19,010
| -33% | -$1.11M |
|
2333
PUT
Abbott
ABT
$178B
| $2.48M | ﹤0.01% |
21,800
-61,500
| -74% | -$7.05M |
|
2334
Tactile Systems Technology
TCMD
$503M
| $2.47M | ﹤0.01% |
152,163
-61,292
| -29% | -$926K |
|
2335
Axcelis
ACLS
$3.38B
| $2.47M | ﹤0.01% |
22,116
-53,116
| -71% | -$6.33M |
|
2336
Prologis
PLD
$128B
| $2.46M | ﹤0.01% |
18,912
-56,979
| -75% | -$7.45M |
|
2337
CALL
Best Buy
BBY
$19.5B
| $2.46M | ﹤0.01% |
30,000
-10,000
| -25% | -$761K |
|
2338
CALL
Vipshop
VIPS
$5.85B
| $2.46M | ﹤0.01% |
148,600
+45,600
| +44% | +$767K |
|
|
LADR
2339
Ladder Capital
LADR
$1.2B
| $2.45M | ﹤0.01% |
220,399
+148,044
| +205% | +$1.63M |
|
2340
DMC Global
BOOM
$127M
| $2.45M | ﹤0.01% |
125,840
-28,491
| -18% | -$499K |
|
2341
CALL
BWX Technologies
BWXT
$13.5B
| $2.44M | ﹤0.01% |
+23,800
| New | +$2.13M |
|
2342
CALL
Gaotu Techedu
GOTU
$508M
| $2.44M | ﹤0.01% |
+372,800
| New | +$1.97M |
|
2343
CALL
Braze
BRZE
$2.77B
| $2.44M | ﹤0.01% |
+55,100
| New | +$2.97M |
|
2344
Kinross Gold
KGC
$33.3B
| $2.44M | ﹤0.01% |
397,718
-224,920
| -36% | -$1.22M |
|
2345
PUT
Applovin
APP
$103B
| $2.44M | ﹤0.01% |
+35,200
| New | +$1.86M |
|
2346
Factset
FDS
$10.1B
| $2.43M | ﹤0.01% |
5,358
+4,458
| +495% | +$2.08M |
|
2347
CryoPort
CYRX
$862M
| $2.43M | ﹤0.01% |
137,431
-52,134
| -28% | -$825K |
|
2348
10x Genomics
TXG
$9.98B
| $2.43M | ﹤0.01% |
64,799
+59,855
| +1,211% | +$2.63M |
|
2349
PUT
Madrigal Pharmaceuticals
MDGL
$12.3B
| $2.43M | ﹤0.01% |
+9,100
| New | +$2.14M |
|
|
RAPT
2350
DELISTED
RAPT Therapeutics
RAPT
| $2.43M | ﹤0.01% |
+33,768
| New | +$4.69M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.